Summary:
To keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data collection, individualized solutions, and supporting business models.
Article written by Jacob Aptekar, Nicholas Donoghoe, Edd Fleming, Meredith Reichert, Erika Stanzl, and Kevin Webster
06|02|2019
Source:
McKensey